Ordinary Index Rebalancing in the Solactive Emerging Markets Healthcare Index | November 2019

In the ordinary rebalance the following composition will be implemented:

3SBIO INC
AIER EYE HOSPITAL GROUP CO-A
AK MEDICAL HOLDINGS LTD
APOLLO HOSPITALS ENTERPRISE
ASPEN PHARMACARE HOLDINGS LT
AUROBINDO PHARMA LTD
AUTOBIO DIAGNOSTICS CO LTD-A
BANGKOK CHAIN HOSPITAL PCL
BANGKOK DUSIT MED SERVICE
Beijing Tongrentang Co Ltd
BIOCON LTD
BUMRUNGRAD HOSPITAL PUB CO
CELLTRION HEALTHCARE CO LTD
CELLTRION INC
CHANGCHUN HIGH & NEW TECH-A
CHINA BIOLOGIC PRODUCTS HOLD
CHINA MEDICAL SYSTEM HOLDINGS LTD
CHONGQING ZHIFEI BIOLOGICA-A
DAEWOONG PHARMACEUTICAL CO
FLEURY SA
FORTIS HEALTHCARE LTD
GENEXINE CO LTD
GENOMMA LAB INTERNACIONAL-B
GENSCRIPT BIOTECH CORP
GREEN CROSS CORP ORD
HANALL BIOPHARMA CO LTD
HANGZHOU TIGERMED CONSULTI-A
HANMI PHARM CO LTD
HANMI SCIENCE CO LTD
HANSOH PHARMACEUTICAL GROUP CO
HAPVIDA PARTICIPACOES E INVE
HARTALEGA HOLDINGS
HELIXMITH CO LTD
HLB INC
HUADONG MEDICINE CO LTD-A
HUALAN BIOLOGICAL ENGINEER-A
HUGEL INC
IHH HEALTHCARE BHD
INNOVENT BIOLOGICS INC
JIANGSU HENGRUI MEDICINE CO LTD CLASS A
JINXIN FERTILITY GROUP LTD
KALBE FARMA TBK PT
LEPU MEDICAL TECHNOLOGY-A
LIFE HEALTHCARE GROUP HOLDIN
LUYE PHARMA GROUP LTD
MEDY-TOX/D
MEZZION PHARMA CO LTD
MICROPORT SCIENTIFIC CORP
MITRA KELUARGA KARYASEHAT TB
NETCARE LTD
NOTREDAME INT SA
ODONTOPREV SA
PING AN HEALTHCARE AND TECHNOL
PIRAMAL ENTERPRISES LTD
QUALICORP SA
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT.
SAMSUNG BIOLOGICS CO LTD
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H
SHANGHAI RAAS BLOOD PRODUC-A
SHENZHEN KANGTAI BIOLOGICA-A
SHENZHEN MINDARY BIO-MEDICAL ELECTRONICS CO LTD
SIHUAN PHARMACEUTICAL HLDGS GRP ORD
SILLAJEN INC
SUN PHARMACEUTICAL INDUS
TOP GLOVE CORP BHD
TOPCHOICE MEDICAL CORP
WALVAX BIOTECHNOLOGY CO-A
WuXi AppTec Co Ltd
WUXI BIOLOGICS CAYMAN INC
YICHANG HEC CHANGJIANG PHA-H
YUHAN CORP ORD
YUNNAN BAIYAO GROUP CO LTD-A
ZAI LAB LTD
ZHANGZHOU PIENTZEHUANG PHA-A